SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Shawn Murphy who wrote (2018)1/15/1997 7:10:00 AM
From: garden_man   of 2281
 
Shawn,

You know as well as I the motivation behind S. Martin. Is he a shareholder, I don't think so. Was he a shareholder, I don't think so. So why spend all the time and effort to post his letter, which by the way (I'm a betting man) he did not send to ADVR.

Granted, he has brought out some issues, but some of this is old info and some of it maybe be just rumor. Some of it maybe just plain poor judgement on Dr H's part.

But you and I both know that he did not send any correspondence to ADVR. Both you and I know that if this stock did not have something, it would be trading in the .01 - .05 range.

The thirty of so MM's currently involved in the stock would be long gone. It is by no means thinly traded. It has not lost the interest of some of the dealers involved in the company.

BYW, just to set the record straight, I did not recommend QUIG. I was just trying to show that a company with a single product, an excellant PR and good management can produce for its shareholders!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News